Breaking News Instant updates and real-time market news.

FL

Foot Locker

$46.10

-2.69 (-5.51%)

17:19
11/20/18
11/20
17:19
11/20/18
17:19

Foot Locker sees Q4 SSS up low to mid single digits

  • 20

    Nov

FL Foot Locker
$46.10

-2.69 (-5.51%)

09/27/18
JEFF
09/27/18
NO CHANGE
Target $60
JEFF
Buy
Foot Locker intra-quarter checks show momentum is building, says Jefferies
Jefferies analyst Janine Stichter says that with two-thirds of Q3 now complete, she looked at various data points to triangulate around Foot Locker's progress intra-quarter. Search interest and site traffic data suggest the Nike Air Max platform is driving growth and that basketball is showing some signs of stabilizing, Stichter tells investors in a research note. The analyst believes momentum is building for Foot Locker and that earnings upside, coupled with multiple expansion, could drive the stock higher. With the stock trading well below historical valuation levels and peers, the market doubts Foot Locker's ability to maintain its positive comp momentum in the second half of 2018, Stichter says. However, she thinks her work reinforces confidence on the company's positive comp and margin trajectory. The analyst reiterates a Buy rating on Foot Locker with a $60 price target.
10/09/18
BARD
10/09/18
NO CHANGE
Target $55
BARD
Neutral
Foot Locker added as Fresh Pick at Baird
Baird analyst Jonathan Komp added the Fresh Pick designation to Foot Locker (FL) shares as Nike's (NKE) improving outlook has increased his near-term conviction the company can deliver better same-store sales. Based on the prospects for better comps in the second half, he is more confident in current estimates and sees an upward bias to valuation. Komp maintained his Neutral rating and raised his price target to $55 from $52 on Foot Locker shares.
11/12/18
COWN
11/12/18
NO CHANGE
Target $56
COWN
Market Perform
Foot Locker price target raised to $56 from $46 at Cowen
Cowen analyst John Kernan raised his price target on Foot Locker to $56 from $46 and also raised his estimates following channel checks which show significantly improved full-price selling trends in North America. Kernan said concerns over long-term growth and margin structure keep him at Market Perform on Foot Locker shares.
11/14/18
LEHM
11/14/18
NO CHANGE
Target $70
LEHM
Overweight
Foot Locker well positioned to meet this quarter's guidance, says Barclays
Barclays analyst Matthew McClintock believes Foot Locker (FL) is well positioned to meet guidance this quarter with further acceleration into Q4 and beyond. The analyst, who acknowledges that comp expectations are likely for flat to slightly negative, says Nike's (NKE) recently reported wholesale revenue growth of 5.2% is a "strong indication of an inflection" in Foot Locker's business. The analyst is estimating a 2.6%, above the 1.8% consensus, increase in comp store sales for Foot Locker and earnings per share of 94c, or a 3c beat. He keeps an Overweight rating on the shares with a $70 price target.

TODAY'S FREE FLY STORIES

LLY

Eli Lilly

$115.20

-1.23 (-1.06%)

06:34
04/22/19
04/22
06:34
04/22/19
06:34
Hot Stocks
Eli Lilly announces licensing, research collaboration with Avidity »

Eli Lilly announced a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 30

    Apr

  • 04

    May

  • 06

    May

  • 07

    May

  • 08

    May

  • 09

    May

  • 18

    May

NGD

New Gold

$0.86

-0.0141 (-1.61%)

06:34
04/22/19
04/22
06:34
04/22/19
06:34
Conference/Events
New Gold management to meet with TD Securities »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 26

    Apr

UBER

Uber

$0.00

(0.00%)

, LYFT

Lyft

$58.31

-1.11 (-1.87%)

06:32
04/22/19
04/22
06:32
04/22/19
06:32
Periodicals
Uber, Lyft IPOs could cause higher fares, WSJ reports »

The initial public…

UBER

Uber

$0.00

(0.00%)

LYFT

Lyft

$58.31

-1.11 (-1.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    May

ONB

Old National Bancorp

$16.85

-0.28 (-1.63%)

06:32
04/22/19
04/22
06:32
04/22/19
06:32
Earnings
Old National Bancorp reports Q1 adjusted EPS 33c, consensus 31c »

Reports Q1 provision for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Apr

  • 02

    May

OKE

Oneok

$69.13

-0.59 (-0.85%)

06:30
04/22/19
04/22
06:30
04/22/19
06:30
Downgrade
Oneok rating change  »

Oneok downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 22

    May

CYAD

Celyad

$21.48

(0.00%)

06:29
04/22/19
04/22
06:29
04/22/19
06:29
Conference/Events
Celyad management to meet with »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 05

    Jun

JPM

JPMorgan

$113.43

-0.86 (-0.75%)

, BTC

Bitcoin

$0.00

(0.00%)

06:26
04/22/19
04/22
06:26
04/22/19
06:26
Periodicals
JPMorgan to expand use of blockchain system to validate payments, FT says »

JPMorgan Chase plans to…

JPM

JPMorgan

$113.43

-0.86 (-0.75%)

BTC

Bitcoin

$0.00

(0.00%)

BITCOIN

Bitcoin

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    May

  • 21

    May

  • 29

    May

  • 03

    Jun

  • 11

    Jun

  • 16

    Jul

OKE

Oneok

$69.13

-0.59 (-0.85%)

06:26
04/22/19
04/22
06:26
04/22/19
06:26
Downgrade
Oneok rating change  »

Oneok downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 22

    May

DTIL

Precision BioSciences

$12.15

-0.84 (-6.47%)

06:23
04/22/19
04/22
06:23
04/22/19
06:23
Initiation
Precision BioSciences initiated  »

Precision BioSciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APC

Anadarko

$64.18

0.16 (0.25%)

, CVX

Chevron

$119.87

-0.38 (-0.32%)

06:20
04/22/19
04/22
06:20
04/22/19
06:20
Downgrade
Anadarko, Chevron rating change  »

Anadarko downgraded to…

APC

Anadarko

$64.18

0.16 (0.25%)

CVX

Chevron

$119.87

-0.38 (-0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 30

    Apr

  • 14

    May

  • 22

    May

RTRX

Retrophin

$20.07

-0.13 (-0.64%)

06:18
04/22/19
04/22
06:18
04/22/19
06:18
Initiation
Retrophin initiated  »

Retrophin initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    May

  • 08

    May

  • 05

    Jun

  • 30

    Jun

MU

Micron

$43.42

0.26 (0.60%)

06:18
04/22/19
04/22
06:18
04/22/19
06:18
Conference/Events
Micron management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 24

    Apr

DTIL

Precision BioSciences

$12.15

-0.84 (-6.47%)

06:18
04/22/19
04/22
06:18
04/22/19
06:18
Initiation
Precision BioSciences initiated  »

Precision BioSciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WTRE

Watford Holdings

$28.24

0.5 (1.80%)

06:17
04/22/19
04/22
06:17
04/22/19
06:17
Initiation
Watford Holdings initiated  »

Watford Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RCII

Rent-A-Center

$21.35

0.07 (0.33%)

06:15
04/22/19
04/22
06:15
04/22/19
06:15
Upgrade
Rent-A-Center rating change  »

Rent-A-Center upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENGIY

Engie SA

$0.00

(0.00%)

, EME

Emcor

$79.55

2.64 (3.43%)

06:15
04/22/19
04/22
06:15
04/22/19
06:15
Periodicals
France's Engie mulls takeover of Emcor, Bloomberg reports »

French energy firm Engie…

ENGIY

Engie SA

$0.00

(0.00%)

EME

Emcor

$79.55

2.64 (3.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAL

Caleres

$27.55

0.425 (1.57%)

06:14
04/22/19
04/22
06:14
04/22/19
06:14
Upgrade
Caleres rating change  »

Caleres upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DOV

Dover

$97.93

1.12 (1.16%)

06:14
04/22/19
04/22
06:14
04/22/19
06:14
Downgrade
Dover rating change  »

Dover downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

TEVA

Teva

$14.36

0.14 (0.98%)

06:13
04/22/19
04/22
06:13
04/22/19
06:13
Hot Stocks
Teva receives FDA approval to market generic nasal spray for opioid overdoses »

The U.S. Food and Drug…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 03

    May

  • 04

    May

RCI

Rogers Communications

$51.39

-1.76 (-3.31%)

06:13
04/22/19
04/22
06:13
04/22/19
06:13
Downgrade
Rogers Communications rating change  »

Rogers Communications…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    May

  • 23

    May

TEVA

Teva

$14.36

0.14 (0.98%)

06:10
04/22/19
04/22
06:10
04/22/19
06:10
Hot Stocks
Teva receives FDA approval to market generic nasal spray for opioid overdoses »

The U.S. Food and Drug…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 03

    May

  • 04

    May

CAL

Caleres

$27.55

0.425 (1.57%)

06:09
04/22/19
04/22
06:09
04/22/19
06:09
Upgrade
Caleres rating change  »

Caleres upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TBK

Triumph Bancorp

$29.38

-1.37 (-4.46%)

06:08
04/22/19
04/22
06:08
04/22/19
06:08
Downgrade
Triumph Bancorp rating change  »

Triumph Bancorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

  • 01

    May

  • 16

    May

OKE

Oneok

06:08
04/22/19
04/22
06:08
04/22/19
06:08
Downgrade
Oneok rating change  »

Oneok downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 22

    May

MANH

Manhattan Associates

$57.31

0.18 (0.32%)

06:07
04/22/19
04/22
06:07
04/22/19
06:07
Upgrade
Manhattan Associates rating change  »

Manhattan Associates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 14

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.